Get the Stockscreener App
2.77
0.00%
0.00
After Hours:
2.82
0.05
+1.81%
Sintx Technologies Inc stock is traded at $2.77, with a volume of 44,425.
It is up +0.00% in the last 24 hours and down -16.06% over the past month.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
See More
Previous Close:
$2.77
Open:
$2.78
24h Volume:
44,425
Relative Volume:
0.23
Market Cap:
$6.95M
Revenue:
$1.23M
Net Income/Loss:
$-8.26M
P/E Ratio:
-0.7152
EPS:
-3.8732
Net Cash Flow:
$-14.65M
1W Performance:
-16.82%
1M Performance:
-16.06%
6M Performance:
-12.89%
1Y Performance:
-45.79%
1-Day Range:
$2.72
$2.84
1-Week Range:
$2.71
$3.08
52-Week Range:
$1.71
$8.5961
Sintx Technologies Inc Stock (SINT) Company Profile
Name
Sintx Technologies Inc
Sector
Industry
Phone
801-839-3516
Address
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Compare SINT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
2.77 | 8.35M | 1.23M | -8.26M | -14.65M | -3.8732 |
|
ABT
Abbott Laboratories
|
123.67 | 229.69B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.64 | 152.68B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
389.40 | 148.84B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
89.61 | 115.21B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.49 | 45.78B | 5.54B | 4.18B | 623.10M | 7.00 |
Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-19 | Initiated | Ascendiant Capital Markets | Buy |
Sintx Technologies Inc Stock (SINT) Latest News
Sintx Technologies Inc. Stock Analysis and ForecastFree Stock Market Forecast Reports - Jammu Links News
What analysts say about Sintx Technologies Inc. stockBreakthrough wealth creation - Jammu Links News
What drives Sintx Technologies Inc. stock priceFree Stock Index Interpretation - Jammu Links News
Is Sintx Technologies Inc. a good long term investmentTremendous growth potential - Jammu Links News
How Sintx Technologies Inc. stock reacts to Fed policy changesHigh Reward Risk Balanced Trading - Newser
What makes Sintx Technologies Inc. stock price move sharplyTriple Return With Stability - Newser
Sintx Technologies (NASDAQ:SINT) Stock Price Down 10.8% – Here’s Why - Defense World
How Sintx Technologies Inc. stock performs during market volatilityFree Capital Allocation Plans - Newser
Why Sintx Technologies Inc. stock attracts strong analyst attentionLow Risk ROI Maximization - Newser
SINTX Technologies Plunges 10.1% Amid Boeing 787 Crash Concerns - AInvest
SINTX Technologies Acquires Surgical Business Assets Of SiNAPTIC Holdings - Nasdaq
SINTX Technologies (SINT) Enhances Strategic Vision to Boost Gro - GuruFocus
SINTX Technologies outlines new strategy to commercialize silicon nitride By Investing.com - Investing.com South Africa
SINTX Technologies Unveils Strategic Vision To Expand Commercialization Across Key Markets - Nasdaq
SINTX Technologies outlines new strategy to commercialize silicon nitride - Investing.com
SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors | SINT Stock News - GuruFocus
SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors - GlobeNewswire
Sintx Technologies (NASDAQ:SINT) Price Target Lowered to $28.00 at Ascendiant Capital Markets - Defense World
SINTX Technologies (SINT) Rating Maintained as Price Target Adju - GuruFocus
Ascendiant cuts SINTX Tech price target to $28, keeps Buy rating By Investing.com - Investing.com South Africa
Ascendiant cuts SINTX Tech price target to $28, keeps Buy rating - Investing.com India
SINTX Technologies (SINT) Rating Maintained as Price Target Adjusted | SINT Stock News - GuruFocus
Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary - MSN
Sintx Technologies Draws Heavy Retail Buzz On New Patent Push, Subsidiary By Stocktwits - Investing.com India
SINTX Technologies expands into agribiotech with new patent - Investing.com Australia
SINTX Technologies expands into agribiotech with new patent By Investing.com - Investing.com South Africa
SINTX Technologies Receives Patent for Antimicrobial Agribiotech Product - mg Magazine
SINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech Market - Koreabizwire
SINTX (SINT) Expands into Agribiotech with New Patent and Subsid - GuruFocus
SINTX Technologies, Inc. Launches Agribiotech Subsidiary Following International Patent Issuance for Silicon Nitride Applications in Agriculture - Nasdaq
SINTX Technologies Announces Patent Issuance and Formation - GlobeNewswire
This Penny Stock Is Surging on Patent News. Analysts Think It Gain 1,300% From Here. - The Globe and Mail
SINTX Technologies Inc reports results for the quarter ended March 31Earnings Summary - TradingView
SINTX Technologies refocuses on medical device market By Investing.com - Investing.com Nigeria
SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device Commercialization - GlobeNewswire
SINTX Technologies (SINT) Advances as a Medical Device Innovator - GuruFocus
SINTX Technologies refocuses on medical device market - Investing.com
SINTX Technologies (SINT) Advances as a Medical Device Innovator | SINT Stock News - GuruFocus
Sintx Technologies Inc Stock (SINT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.28%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):